Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 6,385 | 7,105 | 6,980 | 9,018 | 7,468 |
| Operating Income | -6,385 | -7,105 | -6,980 | -9,018 | -7,468 |
| Other Income | -845 | 1,056 | 1,102 | 1,264 | 1,239 |
| Pre-tax Income | -7,230 | -6,049 | -5,878 | -7,754 | -6,229 |
| Net Income Continuous | -7,230 | -6,049 | -5,878 | -7,754 | -6,229 |
| Net Income | $-7,230 | $-6,049 | $-5,878 | $-7,754 | $-6,229 |
| EPS Basic Total Ops | -0.06 | -0.05 | -0.05 | -0.06 | -0.05 |
| EPS Basic Continuous Ops | -0.06 | -0.05 | -0.05 | -0.06 | -0.05 |
| EPS Diluted Total Ops | -0.06 | -0.05 | -0.05 | -0.06 | -0.05 |
| EPS Diluted Continuous Ops | -0.06 | -0.05 | -0.05 | -0.06 | -0.05 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.05 | -0.05 | -0.06 | -0.05 |
| EBITDA(a) | $-6,381 | $-7,101 | $-6,975 | $-9,004 | $-7,465 |